EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,478 | -13.0% | 119 | -13.1% | 0.00% | -100.0% |
Q3 2022 | $4,000 | 0.0% | 137 | +39.8% | 0.00% | 0.0% |
Q2 2022 | $4,000 | +300.0% | 98 | +600.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,000 | – | 14 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |